Vincent Martin, director of the Headache and Facial Pain Center at the University of Cincinnati, US, said weather change is one of the most common trigger factors of migraine.
The study looked at the use of the drug fremanezumab and whether it could prevent headaches caused by high temperatures.
Fremanezumab is given by injection under the skin and is part of a set of monoclonal antibodies that have come to market in the past six years to treat migraine patients.
The researchers cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 0.12 degrees Celsius, the incidence of any headache increased by 6 percent.
However, during the fremanezumab treatment period, the association completely disappeared.
"This study is the first to suggest that migraine-specific treatments that block calcitonin gene-related peptide (CGRP) can treat headaches associated with the season," said Fred Cohen, a study co-author and Icahn. said the assistant professor of medicine at the School of Medicine. At Mount Sinai in New York.
If the results are confirmed in future studies, drug therapy has the potential to help many people who suffer from seasonal migraines.
Hippocrates, the father of medicine, believed that weather and medicine were closely related.
"After a few thousand years, we're proving that weather matters to human health," said study co-author Al Peterlin, retired chief meteorologist at the U.S. Department of Agriculture.
The study's findings were to be presented over the weekend at the American Headache Society's 66th Annual Scientific Meeting in San Diego, California.
The study looked at the use of the drug fremanezumab and whether it could prevent headaches caused by high temperatures.
Fremanezumab is given by injection under the skin and is part of a set of monoclonal antibodies that have come to market in the past six years to treat migraine patients.
The researchers cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 0.12 degrees Celsius, the incidence of any headache increased by 6 percent.
However, during the fremanezumab treatment period, the association completely disappeared.
"This study is the first to suggest that migraine-specific treatments that block calcitonin gene-related peptide (CGRP) can treat headaches associated with the season," said Fred Cohen, a study co-author and Icahn. said the assistant professor of medicine at the School of Medicine. At Mount Sinai in New York.
If the results are confirmed in future studies, drug therapy has the potential to help many people who suffer from seasonal migraines.
Hippocrates, the father of medicine, believed that weather and medicine were closely related.
"After a few thousand years, we're proving that weather matters to human health," said study co-author Al Peterlin, retired chief meteorologist at the U.S. Department of Agriculture.
The study's findings were to be presented over the weekend at the American Headache Society's 66th Annual Scientific Meeting in San Diego, California.
